NO934832L - Farmasöytisk sammensetning for forhindring eller behandling av arterioscherose - Google Patents

Farmasöytisk sammensetning for forhindring eller behandling av arterioscherose

Info

Publication number
NO934832L
NO934832L NO934832A NO934832A NO934832L NO 934832 L NO934832 L NO 934832L NO 934832 A NO934832 A NO 934832A NO 934832 A NO934832 A NO 934832A NO 934832 L NO934832 L NO 934832L
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
arterioscherosis
prevention
treatment
prevent
Prior art date
Application number
NO934832A
Other languages
English (en)
Other versions
NO934832D0 (no
Inventor
Yusuke Satoh
Toshifumi Inami
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of NO934832D0 publication Critical patent/NO934832D0/no
Publication of NO934832L publication Critical patent/NO934832L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Farmasøytisk sammensetning inneholdende glimepirid som aktiv ingrediens. Sammensetningen blir benyttet for å forhindre eller behandle arteriosclerosis uten noen påvirkning av lipldmetabolisme og uten økning av plasmainsulin-nivå.
NO934832A 1992-12-28 1993-12-27 Farmasöytisk sammensetning for forhindring eller behandling av arterioscherose NO934832L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34747692A JP3465247B2 (ja) 1992-12-28 1992-12-28 動脈硬化症の予防および治療剤

Publications (2)

Publication Number Publication Date
NO934832D0 NO934832D0 (no) 1993-12-27
NO934832L true NO934832L (no) 1994-06-29

Family

ID=18390484

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934832A NO934832L (no) 1992-12-28 1993-12-27 Farmasöytisk sammensetning for forhindring eller behandling av arterioscherose

Country Status (12)

Country Link
US (1) US5416105A (no)
EP (1) EP0604853A3 (no)
JP (1) JP3465247B2 (no)
KR (1) KR940013503A (no)
CN (1) CN1104888A (no)
AU (1) AU666992B2 (no)
CA (1) CA2112195A1 (no)
HU (1) HUT69398A (no)
IL (1) IL108197A0 (no)
NO (1) NO934832L (no)
PL (1) PL301653A1 (no)
ZA (1) ZA939707B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631275A (en) * 1993-12-30 1997-05-20 Hoechst Aktiengesellschaft Substituted benzenesulfonylureas and -thioureas, preparation processes and possible uses of pharmaceutical preparations based on these compounds
EP0835115B1 (en) * 1995-06-30 2004-05-06 ZymoGenetics, Inc. 4-(2-(n-2-carboxamidoindole)aminoethyl)-benzenesulfonamides or sulfonylureas as pdgf antagonists
KR100413745B1 (ko) * 1995-08-30 2004-03-20 정규범 컨버터스위치의스위칭손실및노이즈저감회로
ES2284829T3 (es) * 2002-01-25 2007-11-16 Laboratorios Silanes, S.A. De C.V. Composicion farmaceutica que se usa para controlar la glucosa en sangre en pacientes con diabetes de tipo 2.
BRPI0414512B8 (pt) 2003-09-17 2021-05-25 Board Of Regentes The Univ Of Texas System composição para reproduzir imagens de um pâncreas e uso desta
KR100698595B1 (ko) * 2003-09-29 2007-03-21 보령제약 주식회사 무정형 또는 준결정형 글리메피리드, 이의 제조방법 및 무정형 또는 준결정형 글리메피리드를 포함하는 약학적조성물
DE102005034484A1 (de) * 2005-07-20 2007-02-01 Alfred E. Tiefenbacher Gmbh & Co.Kg Verfahren zur Herstellung von Glimepirid enthaltenden pharmazeutischen Zusammensetzungen
MXPA05009633A (es) * 2005-09-08 2007-03-07 Silanes Sa De Cv Lab Composicion farmaceutica estable de glimepirida de liberacion inmediata y metformina de liberacion prolongada.
TR201101809A1 (tr) 2010-12-21 2012-07-23 Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Vildagliptin ve glimepirid kombinasyonları.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2951135A1 (de) * 1979-12-19 1981-06-25 Hoechst Ag, 6230 Frankfurt Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
US4411903A (en) * 1980-08-11 1983-10-25 American Cyanamid Company 4-[(Monosubstituted-alkyl)amino]benzoic acids and analogs as hypolipidemic and antiatherosclerotic agents
CA1339784C (en) * 1988-06-23 1998-03-31 Shinya Inoue Pyrrolecarboxylic acid derivatives

Also Published As

Publication number Publication date
KR940013503A (ko) 1994-07-15
ZA939707B (en) 1994-08-29
IL108197A0 (en) 1994-04-12
US5416105A (en) 1995-05-16
HUT69398A (en) 1995-09-28
CN1104888A (zh) 1995-07-12
JPH06192088A (ja) 1994-07-12
AU5270693A (en) 1994-07-07
CA2112195A1 (en) 1994-06-29
HU9303758D0 (en) 1994-04-28
NO934832D0 (no) 1993-12-27
JP3465247B2 (ja) 2003-11-10
AU666992B2 (en) 1996-02-29
PL301653A1 (en) 1994-07-11
EP0604853A3 (en) 1994-08-24
EP0604853A2 (en) 1994-07-06

Similar Documents

Publication Publication Date Title
NO931267L (no) Fremgangsmaate for behandling eller forebyggelse av type 1diabetes ved oral administrering av insulin
BG97678A (en) Beta -carotene and/or vitamin e therapy for inhibition of major vascular events
IL108007A (en) USE OF AN INTERFERON-GAMMA (IFN-gamma) INHIBITOR IN THE PREPARATION OF A MEDICAMENT FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE
BR9801008A (pt) Formulação aerossol adequada para terapia, profilaxia ou contenção de infecções da mycobacterium tuberculosis de um pacientes sofrendo de tuberculose
ATE184792T1 (de) 2-bromomelatonin zur behandlung von schlafstörungen
MX9606732A (es) Compuestos terapeuticos.
RU94020410A (ru) Способ лечения или профилактики рвоты у млекопитающих и человека с использованием некоторых хинуклидиновых, пиперидиновых, азанорборнановых, этилендиаминовых производных и родственных им соединений
FI964332A (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
NO934832L (no) Farmasöytisk sammensetning for forhindring eller behandling av arterioscherose
NO166939C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive carboxylsyrederivater.
NO951240D0 (no) Anvendelse av IL-10 til forebyggelse eller behandling av insulinavhengig diabetes mellitus
WO1987000432A3 (en) Use of melatonin or related compounds for the treatment of psoriasis
AP9801286A0 (en) Therapeutic compounds.
RU94045866A (ru) Применение бисфенилалкилпиперазинов для лечения расстройств, вызванных злоупотреблением веществами, способ лечения
NO941915L (no) Madikament for nervebeskyttelse
ITRM920222A0 (it) Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
RU94040886A (ru) Применение производных мелатонина для лечения нарушений сна, фармацевтическая композиция
LV10839A (lv) Arstniecibas lidzeklis lipidu un holesterina vielmainas traucejumu profilaksei un arstesanai so traucejumu profilakses un arstesanas panemiens
AU564439B2 (en) Pharmaceutical compositions containing l-alpha- glycerylphosphorylcholine
BR9702284A (pt) Método cosmético para tratamento e prevenção dos sinais de envelhecimento da pele
ES2123005T3 (es) Composicion farmaceutica que contiene carbacol y otras sustancias colinergicas.
GR3019819T3 (en) Use of wild garlic for the therapy or prevention of blood circulation disturbances.
ATE141510T1 (de) Arzneimittel enthaltend cd14
DK0722325T3 (da) Præparat til behandling eller forebyggelse af herpes
NO962503L (no) Anvendelse av penoksyfyllin ved behandling av multippel sklerose